In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Taarak Mehta Ka Ooltah Chashmah: TV actor Dilip Joshi is celebrating his 54th birthday today. Jet
The Supreme Court has made a historic decision to abrogate Articles 370 and 35 (A). The apex cour
IPL 2024 is now slowly moving towards its peak. Mumbai Indians have become the first team to
Corona cases are increasing in the country. In the last week, 752 new cases of corona have been r
Tecno Camon 19: Tecno's camera-centric smartphone with great offers to be launched in India soon
Tecno Camon 19 Launch: Tecno has announced the launch of its upcoming smartphone Tecno Camon 19 i
The BJP has served a notice to the Speaker over alleged inaccuracies in the speech of the Leader
Manipur Violence The incidents of violence in Manipur are not taking the name of stopping. Interm
In the last 24 hours, 4482 new infections have been reported in Delhi. At the same time, 265 peop
The very sad news is coming from the Bollywood world. Veteran Hindi cinema director Partho Ghosh,
The responsibility of the Uttar Pradesh Teacher Eligibility Test (UP-TET) paper leak case has fal
